(11) 98705-3426
TrademarkIQ iconTrademarkIQ
Back to search
Official data from USPTO

MINK

Did you know this trademark is already registered in United States?

Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.

Active USPTO registrationType: WordOffice: United States

Quick snapshot

MINK

ST13

US500000090779238

Class

5, 42

Filing

90779238

Registration

8145606

Risk and opportunity diagnosis

Executive reading for naming, filing, and monitoring decisions.

USPTO status

Active USPTO registration

Case type

Application and registration

Recorded events

49

Latest update

02/17/2026

Trademark type

Word

Nice classes

5, 42

Filing date

06/17/2021

Registration date

02/17/2026

Expiration date

-

Complete case details

Structured fields from the responsible authority and the official record.

Status date

02/17/2026

Last transaction

02/17/2026

Responsible office

United States Patent and Trademark Office

Status code

700

Official register

Principal Register

Filing basis

Intent to use

First use anywhere

12/01/2021

First use in commerce

12/01/2021

Drawing code

4

Owner type

03

Owner location

Lexington, MA

Examiner

LORENZO, KATHLEEN H

Law office

L90

Current location

PUBLICATION AND ISSUE SECTION

Holders and representatives

Holders

MINK THERAPEUTICS, INC.
MINK THERAPEUTICS, INC.
AgenTus Therapeutics, Inc.

Representatives

Christina M. Licursi WOLF, GREENFIELD & SACKS, P.C.

Technical classification

Nice Classes

Class 5Class 42

Vienna Codes

No Vienna codes available.

Goods and services

Class 5

Cells for medical or clinical use; pharmaceutical and biopharmaceutical agents for the treatment of cancerinfectious diseaseautoimmune disorderstransplant rejectionsinflammatory disease; pharmaceutical and biopharmaceutical preparations and substances for the treatment of cancerinfectious diseaseautoimmune disorderstransplant rejectionsinflammatory disease; biological preparationscell therapies for the treatment of cancerinfectious diseaseautoimmune disorderstransplant rejectionsinflammatory disease

Class 42

Pharmaceuticalmedicalscientificbiopharmaceutical research and development

Publications

History of USPTO decisions and trademark events.

49 publications found

NRCC

NOTICE OF REGISTRATION CONFIRMATION EMAILED

02/17/2026

R.PR

REGISTERED-PRINCIPAL REGISTER

02/17/2026

SUNA

NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED

01/27/2026

CNPR

ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED

01/27/2026

TEME

TEAS/EMAIL CORRESPONDENCE ENTERED

11/25/2025

CRFA

CORRESPONDENCE RECEIVED IN LAW OFFICE

11/25/2025

ALIE

ASSIGNED TO LIE

11/25/2025

TROA

TEAS RESPONSE TO OFFICE ACTION RECEIVED

11/12/2025

GNRN

NOTIFICATION OF NON-FINAL ACTION E-MAILED

08/12/2025

GNRT

NON-FINAL ACTION E-MAILED

08/12/2025

CNRT

SU - NON-FINAL ACTION - WRITTEN

08/12/2025

SUPC

STATEMENT OF USE PROCESSING COMPLETE

07/05/2025

IUAF

USE AMENDMENT FILED

06/23/2025

EISU

TEAS STATEMENT OF USE RECEIVED

06/23/2025

EXRA

NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED

04/03/2025

EX5G

SOU EXTENSION 5 GRANTED

04/02/2025

AITU

CASE ASSIGNED TO INTENT TO USE PARALEGAL

04/02/2025

EXT5

SOU EXTENSION 5 FILED

12/18/2024

EEXT

SOU TEAS EXTENSION RECEIVED

12/18/2024

EXRA

NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED

06/14/2024

EX4G

SOU EXTENSION 4 GRANTED

06/14/2024

EXT4

SOU EXTENSION 4 FILED

06/14/2024

EEXT

SOU TEAS EXTENSION RECEIVED

06/14/2024

EXRA

NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED

12/19/2023

EX3G

SOU EXTENSION 3 GRANTED

12/15/2023

EXT3

SOU EXTENSION 3 FILED

12/15/2023

EEXT

SOU TEAS EXTENSION RECEIVED

12/15/2023

EXRA

NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED

06/22/2023

EX2G

SOU EXTENSION 2 GRANTED

06/20/2023

EXT2

SOU EXTENSION 2 FILED

06/20/2023

EEXT

SOU TEAS EXTENSION RECEIVED

06/20/2023

EXRA

NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED

12/23/2022

EX1G

SOU EXTENSION 1 GRANTED

12/21/2022

EXT1

SOU EXTENSION 1 FILED

12/21/2022

EEXT

SOU TEAS EXTENSION RECEIVED

12/21/2022

NOAM

NOA E-MAILED - SOU REQUIRED FROM APPLICANT

06/21/2022

NPUB

OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED

04/26/2022

PUBO

PUBLISHED FOR OPPOSITION

04/26/2022

NONP

NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED

04/06/2022

CNSA

APPROVED FOR PUB - PRINCIPAL REGISTER

03/21/2022

TEME

TEAS/EMAIL CORRESPONDENCE ENTERED

03/16/2022

CRFA

CORRESPONDENCE RECEIVED IN LAW OFFICE

03/15/2022

TROA

TEAS RESPONSE TO OFFICE ACTION RECEIVED

03/15/2022

GNRN

NOTIFICATION OF NON-FINAL ACTION E-MAILED

03/09/2022

GNRT

NON-FINAL ACTION E-MAILED

03/09/2022

CNRT

NON-FINAL ACTION WRITTEN

03/09/2022

DOCK

ASSIGNED TO EXAMINER

03/09/2022

ASGN

AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP

11/17/2021

NWOS

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

09/02/2021

Continuous trademark protection

Get notified about every new filing that threatens MINK or your mark.

Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.